Primary (n = 95) | Non-primary (n = 12) | P value | |
---|---|---|---|
Maternal age, years | 29.12 ± 5.12 | 27.77 ± 4.60 | 0.452 |
Maternal chronic disease | 14 (15.1%) | 3 (27.3%) | 0.382 |
High professional risk | 19 (20%) | 2 (16.7%) | 0.999 |
Obstetrical history | |||
Parity | 2.24 ± 1.21 | 2.16 ± 1.69 | 0.848 |
Live births | 2.03 ± 0.93 | 2.0 ± 1.41 | 0.918 |
Abortions | 0.21 ± 0.74 | 0.17 ± 0.39 | 0.847 |
Parity, with living children (≥1) | 75 (78.9%) | 7 (58.3%) | 0.146 |
Complications during pregnancy | 9 (9.9%) | 4 (33.3%) | 0.038 |
Medication use during pregnancy | 16 (16.8%) | 6 (50%) | 0.016 |
Febrile disease at CMV diagnosis | 31 (38.8%) | 1 (8.3%) | 0.103 |
Gestational age at CMV diagnosis: | 19.50 ± 8.38 | 19.16 ± 13.51 | 0.928 |
1st trimester | 44 (46.3%) | 3 (25%) | 0.318 |
2nd trimester | 42 (44.2%) | 1 (8.3%) | 0.03 |
3rd trimester | 9 (9.5%) | 2 (16.7%) | 0.356 |
Maternal serology at CMV diagnosis | |||
Positive IgG | 81 (85.3%) | 12 (100%) | <.0001 |
IgG Seroconversion | 79 (83.1%) | -- | -- |
Positive IgM | 72 (75.8%) | 3 (25%) | 0.0008 |
Low avidity IgG | 33 (34.7%) | -- | -- |